Giving Extra This Holiday Season With Big Savings From Five Below

(NASDAQ:FIVE), PHILADELPHIA, PA, Nov. 06, 2025 (GLOBE NEWSWIRE) — Five Below, Inc. (NASDAQ: FIVE), the trend-right, extreme-value brand for kids is once again decking the aisles of stores nationwide with must-have gifts and decor, making it easy to give extra this holiday season. Whether you're on the search for show-stopping toys and games, stocking stuffers […]

Streamex Corp. to Participate at the Cantor Fitzgerald Crypto & AI/Energy Infrastructure Conference on November 10-12, 2025

(NASDAQ:STEX), LOS ANGELES, Nov. 06, 2025 (GLOBE NEWSWIRE) — Streamex Corp. (“Streamex” or the “Company”) (NASDAQ: STEX), a leader in institutional-grade tokenization of real-world assets, today announced Henry McPhie, CEO and Co-Founder, will participate at the Cantor Crypto & AI/Energy Infrastructure Conference, taking place on November 10-12, 2025, at The Ritz-Carlton South Beach in Miami

Longtime Entrepreneur and Community Leader Opens AtWork in Columbus

COLUMBUS, Ohio, Nov. 06, 2025 (GLOBE NEWSWIRE) — AtWork(R), the nation's leading staffing franchise for empowering job seekers and facilitating company growth, has opened its newest location in Whitehall at 3606 E. Main St, situated inside the same retail complex as Clover Kids Dental. AtWork Columbus Southeast is locally owned by James Jackson, a longtime

Cority set to launch its artificial intelligence suite at new global event

TORONTO, Nov. 06, 2025 (GLOBE NEWSWIRE) — Cority, a global leader in EHS and sustainability software, today announced plans to unveil a wave of new AI capabilities at its upcoming virtual launch event, Converge Studio, on Thursday, December 4th. The announcement comes at a pivotal moment for EHS+ professionals. Artificial intelligence is beginning to open

Xenon to Present at Upcoming Investor Conferences

(NasdaqGM:XENE), VANCOUVER, British Columbia and BOSTON, Nov. 06, 2025 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need, today announced that the Company will present at two upcoming investor conferences. Stifel 2025 Healthcare ConferenceThursday, November 13, 2025

KraneShares Humanoid Robotics ETF (Ticker: KOID) Approved On Stifel Platform

(NasdaqGM:KOID), NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) — KraneShares, a leading provider of exchange-traded funds (ETFs) delivering access to emerging technologies and innovative global asset classes, today announced that the KraneShares Global Humanoid and Embodied Intelligence Index ETF (Ticker: KOID) has been approved on Stifel's investment platform, expanding availability to the firm's extensive network

Runway Growth Finance Corp. Announces Fourth Quarter 2025 Dividend of $0.33 per Share

(NASDAQ:RWAY), MENLO PARK, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) — Runway Growth Finance Corp. (Nasdaq: RWAY) (“Runway Growth” or the “Company”), a leading provider of flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity, today announced that its Board of Directors has declared a fourth quarter 2025 cash distribution of

Disc Medicine Reports Third Quarter 2025 Financial Results and Provides Business Update

(NasdaqGM:IRON), Submitted a New Drug Application (NDA) for accelerated approval of bitopertin in erythropoietic protoporphyria (EPP) on September 29, 2025; Awarded the FDA Commissioner's National Priority Voucher (CNPV), which is designed to shorten the expected NDA review period to 1-2 months from NDA acceptance Acceleration of ongoing efforts to support the potential earlier approval and

Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2025 Financial Results

(NASDAQ:ALGS), SOUTH SAN FRANCISCO, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today reported recent business progress and financial results for the third quarter 2025. “Our Phase 2 B-SUPREME study of pevifoscorvir

Bath & Body Works to Report Third Quarter Results on November 20, 2025

(NYSE:BBWI), COLUMBUS, Ohio, Nov. 06, 2025 (GLOBE NEWSWIRE) — Bath & Body Works, Inc. (NYSE: BBWI) announced today that it plans to report its third quarter 2025 financial results before market open on Thursday, November 20, 2025. In conjunction with this report, the company will host a conference call at 8:30 a.m. ET during which

Scroll to Top